Clinical Trial Update: Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating quality of life in soft tissue sarcoma patients receiving palliative chemotherapy or pazopanib was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Soft Tissue Sarcoma Adult | Phase 4 | Status: TERMINATED